Therwil, Switzerland

Peter Marbach

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Novartis Ag, Artificial Sensing Instruments Asi Ag, Balzers Aktiengesellschaft. Active years: 1998-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Marbach. Retrieved from https://idiyas.com/inventor/peter-marbach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

 

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 165(Granted Patents)


Company Filing History:


Years Active: 1998-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Peter Marbach - Innovative Inventor from Therwil, Switzerland

Introduction: Peter Marbach is a renowned inventor hailing from Therwil, Switzerland, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Peter Marbach holds several patents in the areas of renewable energy, sustainable agriculture, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Peter Marbach has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Peter Marbach has collaborated with top companies, banks, and research institutions, fostering a culture of innovation and driving forward progress in the global technological landscape.

Conclusion: Peter Marbach's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor, shaping the future of technology and leaving a lasting impact on society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…